Oxygen Therapy Devices Market By Product Type (Oxygen Concentrators, Oxygen Cylinders, Oxygen Delivery Devices, Oxygen Therapy Accessories), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Pulmonary Hypertension, Other Respiratory Disorders, Emergency and Acute Care, Postoperative Care), By Portability (Portable Oxygen Devices, Stationary Oxygen Devices), By Capacity (Oxygen Concentrators {Small Concentrators (<5 liters), Medium Concentrators (5-10 liters), Large Concentrators (>10 liters)}, Oxygen Cylinders {Small Cylinders (<600 liters), Medium Cylinders (600 to 2000 liters), Large Cylinders (>2000 liters)}, Liquid Oxygen Systems {Small Liquid Oxygen Tanks (<3 liters), Medium Liquid Oxygen Tanks (3-10 liters), Large Liquid Oxygen Tanks (>10 liters)}), and By End-User (Hospitals, Home Care Settings, Ambulatory Surgical Centers, Others), Global Market Size, Segmental analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Oxygen Therapy Devices market accounted for USD 5.2 Billion in 2024 and is expected to reach USD 14.25 Billion by 2035, growing at a CAGR of around 9.6% between 2025 and 2035. The oxygen treatment devices market refers to healthcare goods used to supply oxygen to people who require additional oxygen beyond what is normally available, such as COPD, asthma, and pneumonia. Such devices include oxygen concentrators, oxygen cylinders, oxygen masks, and portable oxygen makeup optimization systems that increase oxygen admission and lung capacity. The demand for these devices stays high as the world's population ages and respiratory problems become common. Another factor contributing to the growth of the oxygen therapy market is technological advancement in portable and home-based oxygen therapy equipment. Further, the growing need for respiratory care and novel technology options such as teleconsultation are accelerating the market. Such growth offers prospects for manufacturers to deliver sophisticated products and services that provide an ideal match for the needs of various sorts of patients.

Report Scope:

Market Dynamics

Increasing respiratory disorders boost the demand for oxygen therapy devices.

The prevalence of respiratory diseases, such as COPD and asthma, increases the need for oxygen therapy equipment. This has been aided by an aging population, poor air quality, and lifestyles that make people vulnerable to respiratory ailments. Technological development has resulted in equipment that is efficient and easy to use, allowing them to achieve their objective. The Global Burden of Disease Study discovered that COPD caused 3 million deaths in 2019, emphasizing the significance of high-quality oxygen therapy. Patients and healthcare practitioners understand the importance of early intervention with oxygen therapy to improve patient's quality of life and health. Furthermore, government support for raising respiratory disease awareness and expanding primary care involvement would benefit this market. The demand for oxygen therapy equipment is rising as the healthcare system prioritizes respiratory health.

Technological advancements improve the efficiency of oxygen delivery systems.

The oxygen therapy devices market has numerous underlying factors that provide its impetus. Firstly, the increasing rate of morbidity and mortality of respiratory diseases, including COPD and asthma, requires proper oxygen delivery supplies. Furthermore, as the world's population ages, people are more likely to suffer from chronic conditions that require respiratory support. Another element driving growth is that portable and more efficient gadgets assist patients in adhering to prescribed regimens, which increases their positive market impact. Further, the growing education level of the population and the greater availability of information about the effectiveness of oxygen therapy contribute to the sales rate. Another important factor is favorable government rules and funding and the growing home health care, which shifts the focus of oxygen therapy away from hospitals and toward homes. These factors combine to raise the market size for oxygen therapy equipment.

Stringent regulations delay product approvals and market entry timelines.

The oxygen therapy devices market is constrained by the industry's stringent regulations and lengthy approval and market penetration processes. FDA, EMA, and other regulatory organizations demand multifaceted testing and documentation to prove the safety of a patient and the efficiency of a device. These lengthy approval processes lengthen firms' development time, and new products may not reach the market on time, resulting in missed market opportunities. Furthermore, the requirements can be difficult for small businesses due to the constant changes in rules. As a result, the rate of innovation for oxygen therapy goods has slowed, aggravating patients' rising need for better oxygen therapy treatment. The relatively conservative regulation can further discourage investments in research and development, which will harm the market for innovative technologies. Thus, the market’s developmental capacity may be limited, which could also harm stakeholders and patients.

Telemedicine integration enhances patient monitoring with oxygen therapy solutions.

The combination of telemedicine with oxygen therapy presents a promising opportunity for the oxygen therapy equipment market. With an increasingly fragmented care delivery model that leans toward remote care, there is a need for connected devices that can feed real-time breathing oxygen data to clinicians. Telemedicine improves the effectiveness of early treatments because treatment plans can be adjusted in response to feedback. It also serves the purpose of increasing the fidelity of the implementation of prescribed healthcare regimens. Further, a rising incidence rate of chronic respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma creates the demand for sophisticated oxygen therapy products. They can increase their presence in the industry by using telehealth technology to produce new gadgets with extra capabilities.

Moreover, the global acceptance of home care is driving market growth in portable and convenient oxygen therapy equipment. Telemedicine's distinct services keep clients interested, and the addition of integrated telemedicine services is expected to provide this firm a competitive advantage in the growing healthcare industry.

Growing home care services increase demand for portable oxygen devices.

The growing demand for home care services has significantly boosted the market for portable oxygen therapy devices. People have recently elected to stay at home during their treatment, increasing the demand for transportable and accessible oxygen delivery. This trend is driven by an increase in the number of patients suffering from respiratory illnesses, an aging population, and technical improvements that make portable devices more effective and user-friendly. Furthermore, increased public health awareness and the rising prevalence of diseases such as chronic obstructive pulmonary disease (COPD) and other respiratory disorders benefit the market. Manufacturers are considering more appealing designs and features to improve patients' mobility and comfort, showing strong development potential in the oxygen therapy device market. Given the trends in new entrants and combination agreements in this area, the industry will have numerous opportunities to grow in the next few years.

Industry Experts Opinion

“As a global leader in sleep health and CPAP therapy, millions of people trust ResMed’s devices to help them sleep better and live healthier lives. We are excited to introduce the AirTouch N30i, a mask that redefines comfort with its soft, natural feel and sleek, modern design. It sets a new standard in CPAP masks, helping more people stay committed to their therapy and achieve better sleep while offering a refined aesthetic that is as pleasing to look at as it is to wear.”

• Justin Leong, Chief product officer at ResMed.

 “Limited availability of oxygen beds is forcing healthcare professionals to recommend home-based oxygen therapy for patients suffering from mild breathing difficulties. This is fueling the demand for portable oxygen concentrators as they extract oxygen from the atmosphere and do not require refills.”

• Gopinadh Gundreddy, a medical devices analyst at GlobalData.

Segment Analysis

Based on the product type, the Oxygen Therapy Devices Market is classified into Oxygen Concentrators, Oxygen Cylinders, Oxygen Delivery Devices, and Oxygen Therapy Accessories. Oxygen concentrators are the most prominent product type segment in the oxygen therapy device market. This is owing to the increased prevalence of chronic respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma, which require long-term oxygen treatment. Oxygen concentrators are used because they can give oxygen for extended periods and are simple to operate and move.

New technologies have also resulted in improved designs that are more efficient and compact, which helps to increase the models' popularity. Rising knowledge of home healthcare and shifts in preferences for noninvasive procedures are among the factors driving the use of oxygen concentrators.

Based on the application, the Oxygen Therapy Devices Market is classified into Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Pulmonary Hypertension, Other Respiratory Disorders, Emergency and Acute Care, and Postoperative Care. In the oxygen therapy devices market, chronic obstructive pulmonary disease (COPD) is the largest category. COPD is a common lung illness characterized by chronic airflow restriction, which increases patients' oxygen demand. The increased prevalence of COPD throughout the world due to factors like smoking and air pollution has placed increased demands on effective oxygen therapy delivery systems.

This need is bolstered by contemporary advances in which manufacturers of portable oxygen concentrators are designing equipment that allows patients to be mobile to receive their therapy consistently. As a result, the COPD sector remains the market's largest, underscoring the need for better chronic respiratory disease care and a greater emphasis on improving patients' quality of life.

Regional Analysis

The North American oxygen therapy devices market is leading due to various respiratory disorders, including COPD and asthma. The growing number of people choosing home healthcare services, combined with an aging population, drives up demand for portable and non-portable oxygen delivery devices.  Several developments, like high-efficiency oxygen concentrators and digitized remote patient monitoring, expand the level of comfort and care for the patient. There is a focus on respiratory disorders, and the necessity for immediate care encourages market growth.

Market access is dependent on regulatory backing, and reimbursement rules are critical for market growth. Furthermore, the introduction of telemedicine solutions alters the approach to oxygen therapy and its control, resulting in improved patient outcomes and availability. Leading market players are focused on aggressive product releases and mergers and acquisitions to strengthen their position in this changing market.

The Asia-Pacific oxygen therapy device market has enormous growth potential due to increased respiratory disorders, pollution levels, and life expectancy. Suppliers and consumer markets such as China and India play a vital role in generating demand, the expansion of healthcare facilities, and growing awareness of diseases like COPD and asthma.

Developments in portable oxygen concentrators and non-invasive ventilators expand market prospects. Government endeavors to expand healthcare facilities and develop trends in lifestyle diseases all contribute to these concerns. Furthermore, the growing number of hospitals and home healthcare services will boost the industry and make it more competitive in the region.

Competitive Landscape

The oxygen therapy devices market is highly competitive and involves both traditional market participants and new entrants who seek to optimize the value for patient caregivers. The industry's top companies, notably Philips Respironics and ResMed, are moving ahead, striving to develop innovative solutions such as cloud-integrated devices for remote monitoring. Users desired Inogen's portable oxygen concentrators to be active, so the company grew stronger. The Invacare manufacturers have released lighter and more energy-friendly models, while Caire Inc. has developed models that are more flexible for patients.

Further, Drive DeVilbiss Healthcare is increasing its portfolio of products with a focus on smart conveniences. AI and machine learning are used to find potential ways to personalize therapy and improve the company's oxygen supply. This dynamic environment is associated with a shift towards patient-centric strategies resulting from the rising incidence of respiratory diseases and an aging population. The market appears to be steadily expanding, with constant investments made in R&D to develop improved therapies.

Oxygen Therapy Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In September 2024, ResMed introduced its first fabric CPAP mask, designed to enhance comfort and user acceptance in sleep apnea treatment. This innovative mask aims to improve overall sleep health by providing a softer, more adaptable fit, encouraging greater adherence to therapy for users seeking a better night's sleep.
• In April 2024, Fisher & Paykel Healthcare Corporation Limited will introduce the F&P Solo Nasal Mask to treat obstructive sleep apnea in the United States. It's the world's first AutoFit mask, which makes setup easier by allowing customers to stretch and modify it with one touch.
• In January 2023, Inogen, Inc. stated that it has met major regulatory milestones in the United States and Europe to enhance its portable oxygen concentrator products. This accomplishment demonstrates the company's continuous commitment to meeting regulatory obligations, as well as its focus on ensuring its goods meet the highest quality and safety standards.

Report Coverage:

By Product Type

• Oxygen Concentrators
• Oxygen Cylinders
• Oxygen Delivery Devices
• Oxygen Therapy Accessories

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Sleep Apnea
• Pulmonary Hypertension
• Other Respiratory Disorders
• Emergency and Acute Care
• Postoperative Care

By Portability

• Portable Oxygen Devices
• Stationary Oxygen Devices

By Capacity

• Oxygen Concentrators
  • Small Concentrators (<5 liters)
  • Medium Concentrators (5-10 liters)
  • Large Concentrators (>10 liters)
• Oxygen Cylinders
  • Small Cylinders (<600 liters)
  • Medium Cylinders (600 to 2000 liters)
  • Large Cylinders (>2000 liters)
• Liquid Oxygen Systems
  • Small Liquid Oxygen Tanks (<3 liters)
  • Medium Liquid Oxygen Tanks (3-10 liters)
  • Large Liquid Oxygen Tanks (>10 liters)

By End-User

• Hospitals
• Home Care Settings
• Ambulatory Surgical Centers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Philips Respironics
• ResMed
• Invacare Corporation
• Drive DeVilbiss Healthcare
• AirSep Corporation
• OxyMed
• DeVilbiss Healthcare
• Nidek Medical Products
• Caire Inc. (a Chart Industries company)
• Breas Medical
• Medtronic
• Hamilton Medical
• GCE Group
• Omron Healthcare
• Inogen

Frequently Asked Questions (FAQs)